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ABSTRACT     The antioxidant, antihistamine, and chemotactic properties of vitamin C provide the theoretical basis linking vitamin C supplementation to combating the common cold; yet, the clinical evidence is mixed. To date, vitamin C intervention trials have not systematically recorded cold symptoms daily or looked at fluctuations in plasma histamine over an extended period.  Also, trials have not been conducted in individuals with marginal vitamin C status.  This study examined the impact of vitamin C supplementation during cold season on specific cold symptoms in a population with low plasma vitamin C concentrations.  Healthy young males who were not regular smokers or training for competitive sports between the ages of 18 and 35 with below average plasma vitamin C concentrations were stratified by age, body mass index, and vitamin C status into two groups:  VTC (500 mg vitamin C capsule ingested twice daily) or CON (placebo capsule ingested twice daily). Participants were instructed to fill out the validated Wisconsin Upper Respiratory Symptom Survey­21 daily for 8 weeks.  Blood was sampled at trial weeks 0, 4, and 8.  Plasma vitamin C concentrations were significantly different by groups at study week 4 and 8.  Plasma histamine decreased 4.2% in the VTC group and increased 17.4% in the CON group between study weeks 0 and 8, but these differences were not statistically significant (p>0.05). Total cold symptom scores averaged 43±15 
for the VTC group compared to 148±36 for the CON group, a 244% increase in 
symptoms for CON participants versus VTC participants (p=0.014). Additionally, 
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recorded symptom severity and functional impairment scores were lower in the 
VCT group than the CON group (p=0.031 and 0.058, respectively). Global 
perception of sickness was 65% lower in the VTC group compared to the CON 
group (p=0.022). These results suggest that 1000 mg of vitamin C in a divided 
dose daily may lower common cold symptoms, cold symptom severity, and the 
perception of sickness.  More research is needed to corroborate these findings.      
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Chapter 1 INTRODUCTION 
 In the course of a year, Americans suffer 1 billion colds. Generally, children 
get 6 to 10 colds a year, and adults get 2 to 4 colds per year (National Institute of 
Allergy and Infectious Diseases, 2001). Seeking treatment for colds is a major 
reason for doctor visits; unfortunately, doctors can do little to treat the illness, as 
antibiotics cannot fight viruses. In fact, misuse of antibiotics as a means to treat 
the common cold contributes to the rise of drug-resistant bacterial infections and 
additional risks for allergic reactions (Anon, 2010).  
 The common cold is known to be caused by over 200 different viruses, 
including rhinoviruses and coronaviruses (NIAD, 2001). The debilitating 
symptoms of the common cold can cause substantial health-related productivity 
losses. Adults on average lose 8.7 work hours per cold incidence (Bramley, 
Lerner, & Sarnes, 2002), and students lose a total of 189 million school days 
annually due to the cold (Fendrick, Monto, Nightengale, & Sarnes, 2003). The 
indirect costs of the common cold, such as missed workdays as well as direct 
costs of care, contribute to a significant burden on the economy. Colds cost 
Americans and their healthcare providers $40 billion per year, putting it ahead of 
conditions such as congestive heart failure, osteoporosis, asthma, and migraines 
(Fendrick et al., 2003).  
 There is no cure for the common cold, however, we are not completely 
defenseless. The immune system utilizes various mechanisms to detect, attack and 
eliminate pathogens including viruses that cause the common cold. Vitamin C 
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consumption is one dietary factor that enhances the immune system and the 
modulation of resistance to respiratory tract infections, reducing the risk, severity, 
and duration of the common cold (Wintergerst, Maggini & Hornig, 2006). 
Vitamin C aids the immune system by decreasing oxidative stress 
(Bandyopadhyay, Das & Banerjee, 1999), enhancing production of the defense 
collagens that populate the pulmonary tissues (Behndig, Blomberg, Helleday, 
Kelly & Mudway, 2009), promoting leukocyte motility, and reducing circulating 
histamine concentrations (Johnston, Martin & Cai, 1992). Clinical trials have 
verified that vitamin C ingestion helps reduce the incidence, severity, and 
duration of common colds (Sasazuki et al., 2005; Elwood, Lee, Leger, Baird, & 
Howard, 1976; Anderson, Reid & Beaton, 1972). 
 In a double-blind, 3-year randomized controlled trial in a Japanese patient 
population, researchers found that vitamin C supplementation reduced the 
frequency of the common cold by 20% (Sasazuki et al., 2005). Additional studies 
have found consistent, statistically significant benefits using regular vitamin C 
prophylaxis indicating its role in respiratory defense mechanisms (Wintergerst, 
Maggini, & Hornig, 2006). Also, individuals exposed to severe physical exercise 
or extreme environmental conditions particularly benefit from vitamin C 
supplementation (Hemila, Chalker, & Douglas, 2007). Previous research on the 
relationship between vitamin C supplementation and the common cold lacks 
conclusiveness due to methodological limitations such as appropriate dosage, 
subject pool, and symptom measurement. The current research examined the 
impact of vitamin C supplementation (1000 mg/d in a divided dose) on cold 
   3 
symptom severity in a population group most at risk for vitamin C deficiency, 
young men, during cold and flu season (January-March) (Schleicher, Carroll, 
Ford, & Lacher, 2009).  
 The purpose of this randomized clinical trial was to examine the effect of 
vitamin C supplementation in young college males, aged 18-35, on reported 
perception of sickness and severity of common cold symptoms at a large 
southwestern university. We hypothesized that vitamin C supplementation (1000 
mg/d, in a divided dose) will have no effect on plasma histamine concentrations. 
Secondly, we hypothesized that there will not be a decrease in reported perception 
of sickness or symptom severity (magnitude of discomfort) of the common cold.  
 When researching the effects of vitamin supplementation, consumption of 
the vitamin through the diet must be controlled. In this study, subjects only had to 
follow a fruit juice restriction. To control for any confounding dietary factors, 
vitamin C consumption was accounted for through two measures. First, 
milligrams of vitamin C consumed per week was calculated using food 
frequencies questionnaires. Second, a validated diet quality survey entitled Rapid 
Eating and Activity Assessment for Participants Short Version (REAPS) was 
conducted at weeks 0 and 8 (Segal-Isaacson, Wylie-Rosett & Gans, 2004). With 
these methods in place, we can conclude that the results of the study are due to the 
vitamin C supplementation and not from an increase in vitamin-C rich foods.  
Definition of Terms 
• Common cold: a syndrome caused by viral infection of the upper 
respiratory tract mucosa. Symptoms include weakness and fatigue, nasal 
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discharge and obstruction, as well as sneezing and sore or ‘scratchy’ 
throat. Headache, congestion, and cough may also be present (Rabkin) 
• Plasma histamine: physiological range for humans is 90 to 800 nmol/L; 
the optimal range of blood histamine has not been identified (Johnston, 
Solomon, & Corte, 1996) 
• Plasma vitamin C: >0.4 mg/dL is adequate; 0.2-0.4 mg/dL is low; <0.2 
mg/dL is deficient (Jacob & Sotoudeh, 2002) 
• BMI: [weight (in pounds) / height (in inches) x height (in inches)] x 703; 
underweight is <18.5, normal is 18.5-24.9, overweight is 25.0-29.9, obese 
is 30 and above (American Dietetics Association, 2011) 
• Regular smoker: greater than or equal to 10 cigarettes per day (Moran, 
Wechsler, & Rigotti, 2004) 
• Social smoker: fewer than 10 cigarettes per day [typically does not smoke 
daily] and smokes mainly with others in a social scene (Schane, Glantz, & 
Ling, 2009; Moran, Wechsler, & Rigotti, 2004) 
• Training athlete: engaging in purposeful exercise 5 or more times per 
week 
Limitations  
• Subject compliance to the protocol, which includes taking the pills, 
restricting all juice consumption, and completing the symptom surveys 
daily. To reduce this limitation, we chose to use the one-page WURSS-21 
and placed forms in a booklet for organization.  
• The nature and severity of the common cold is a very subjective measure. 
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We examined the perception of sickness as well as severity of cold 
symptoms reported.  
• The time of day in which subjects filled out the WURSS-21 questionnaire 
was not specified. It is possible that symptoms of the cold are worse/less at 
different times of the day.  
• The time period of the study did not overlap various seasons and only 
lasted for 8 weeks. It is possible that a longer time period is necessary to 
get valid results. 
Delimitations 
 Subjects were healthy college men, aged 18-35, at Arizona State University. 
Exclusion criteria for subjects included regular smoking, BMI > 35 or use of 
dietary supplements and/or prescription medications. Subjects’ vitamin C plasma 
concentrations had to be <0.79 mg, and a weekly food frequency questionnaire 
was used to estimate mg of vitamin C from dietary intake. Diet quality was also 
assessed through a REAPS survey. Training athletes or those who engaged in 
purposeful exercise more than 5 times a week were excluded. The study lasted 
from mid-February to the end of May 2011.  
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Chapter 2 LITERATURE REVIEW 
Vitamin C Overview 
 History. The history of vitamin C can be classified into three periods 
(Jacob, 1996). The first period took place between the sixteenth and nineteenth 
centuries and involved the investigation of the cause and cure of scurvy. The 
second period occurred between 1900 and 1980 and is defined by the chemical 
isolation and characterization of ascorbic acid. It was during this time that 
ascorbic acid was identified as being necessary to prevent scurvy. The last period, 
from 1980 until present, includes the exploration of the roles vitamin C can have 
in optimizing human health and preventing disease.  
 Accounts of scurvy most notably occurred during the sixteenth and 
eighteenth centuries. Seamen commonly complained of symptoms such as 
bleeding gums, bruising on extremities, swollen joints, and a red blotchy skin 
irritation called petecheai (Hughes, 2010). Although there is some controversy 
over the discovery of a cure for scurvy, James Lind is credited with conducting 
one of the first recorded accounts of a controlled clinical trail that labeled scurvy 
as a nutrient deficient illness (Bartholomew, 2002). In May 1747, Lind was 
working on the HMS Salisbury as a naval surgeon where he isolated 12 scurvy 
patients experiencing similar symptoms. He paired them off and prescribed 
various treatment remedies including vinegar, mustard and garlic purges, as well 
as oranges and lemons. The only pair to quickly recover from their scurvy 
symptoms was the two prescribed to incorporate oranges and lemons into their 
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diet (Bartholomew, 2002). In an excerpt from James Lind’s personal 
documentation of the experiment, he illustrates the details of the recovery: 
 The consequence was that the most sudden and visible good effects 
were perceived from the use of the oranges and lemons; one of those 
who had taken them being at the end of six days fit for duty. The spots 
were not indeed quite off his body, nor his gums sound; but without any 
other medicine than a gargarism or elixir of vitriol he became quite 
healthy before we came into Plymouth, which was the 16th of June 
(Bruzelius, 1996). 
 After years of testing various hypotheses to cure the symptoms of scurvy, 
evidence that lack of a nutrient from citrus foods was the cause prompted the 
British navy to begin supplying lime juice on crew ships in order to prevent 
scurvy in the early 1800’s (Hughes, 2010). This discovery introduced an effective 
treatment measure and established scurvy as a nutritional disease worldwide 
(Clemetson, 1989). Although a reliable treatment had been identified and deaths 
due to scurvy decreased, the pathophysiology was not yet understood. 
 The second period of vitamin C history began in 1907 when two 
Norwegian scientists, Axel Holst and Alfred Frohlich, were studying the 
development of beriberi in guinea pigs (Holst & Frohlich, 1907). Unexpectedly, 
symptoms of scurvy resulted. Holst and Frohlich discovered that the guinea pigs 
were cured of their scurvy symptoms through a diet high in fruits and vegetables. 
This discovery was a tremendous breakthrough for future research because it 
unveiled an experimental mode to study scurvy. 
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 Almost twenty years after the identification of scurvy as a vitamin 
deficiency by Casimir Funk in 1912, Albert Szent-Gyorgyi in Europe and Glenn 
King in the United States successfully isolated “hexuronic acid” from citrus 
(Szent-Gyorgyi, 1928). The substance was shown to completely reverse the 
symptoms of scurvy and was later named ascorbic acid. The isolation of the 
compound allowed for the identification of its chemical and physical 
characteristics. 
 After these advancements in the discovery of vitamin C, research explored 
the proper metabolic needs for humans to prevent scurvy. Furthermore, studies 
were conducted to see if there were benefits of taking high doses of the 
supplement to improve health through roles such as immunocompetence and 
antioxidant protection (Jacob, 1996).  
 Biochemistry, Absorption & Metabolism. Vitamin C is a water-soluble 
vitamin that exists primarily in its reduced form in the body, ascorbic acid (AA). 
The active form of AA (L-ascorbic acid) is composed of a 6-carbon α-ketolactone 
with two enolic hydrogen atoms, which allows it to donate hydrogens and 
therefore reduce moledules (Rose & Bode, 1993). AA is exceptionally resilient in 
that it is readily recycled intracellularly from its oxidized form, dehydroascorbic 
acid (DHA) through chemical reduction by glutathione and enzymatic reduction 
(Park & Levine, 1996). The typical amount of vitamin C in the blood (35 µM) can 
be completely regenerated every 3 minutes (Mendiratta, Qu & May, 1998).  
 Through evolution, humans, guinea pigs, fruit bats, and primate monkeys 
lost their ability to synthesize vitamin C from glucose. This is because they lack 
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the enzyme, gulonolactone oxidase, which catalyzes the last enzymatic step in the 
synthesis of ascorbate (Chatterjee & De, 1969) Instead, the vitamin must be 
obtained through the diet. Vitamin C is absorbed across the brush border of the 
small intestine through different mechanisms, namely two different sodium-
dependent cotransporters, SVCT1 and SVCT2 (Tskaguchi et al., 1999). SVCT1 is 
expressed on epithelial tissues of the intestine and kidney as well as inside the 
liver (Tskaguchi et al., 1999). SVCT2 is found in a number of tissues including 
neurons and bone. The distribution of the two transporters suggests that SVCT1 is 
involved in the bulk of AA transport and homeostasis while SVCT2 is involved in 
tissue-specific uptake of AA (Hediger, 2002).  
 Ascorbate accounts for 80-90% of vitamin C content in food products 
(Vanderslice & Higgs, 1991); however, prior to absorption, AA can be oxidized 
to form dehydroascorbate (DHA). DHA can also be absorbed through facilitated 
diffusion using sodium-independent carriers with the aid of glucose transporters, 
especially GLUT1 and GLUT3 (Wilson, 2005). Because of its dependence on 
glucose transporters, extracellular glucose has an inhibitory effect on DHA 
absorption (Washko & Levine, 1992). Once inside the cell, DHA is rapidly 
reduced back to AA by glutathione or enzymatic reduction.  
 The absorption of ingested AA depends highly on dosage and the resulting 
biovailability. Intakes of 30-180 mg of AA per day result in approximately 70-
90% absorption; however, absorption decreases to less than 50% when doses are 
greater than 1 gram (Institute of Medicine, 2000). Additional research further 
supports this dose-response relationship concluding that a 20 mg dose can reach 
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98% absorption, yet higher doses of 12 g only have a 16% absorption rate (Levine 
et al., 1996). Some studies have shown that intakes between 100 and 200 mg 
vitamin C elevate plasma concentrations to ~1.0 mg/dL, maximizing the body 
pool (Kallner, Hartmann & Hornig, 1979). However, there is evidence that a 
single daily dose of 100-200 mg only allows for tissue saturation, and >500 
mg/day is necessary to achieve plasma saturation (Johnston & Cox, 2001). When 
plasma saturation is achieved, antioxidant protection can be maximized. 
 After absorption, AA is transported primarily as an ascorbate anion in 
plasma (Wilson, 2005). For a healthy adult, plasma concentrations of AA range 
from 0.4 to 1.7 mg/dL; less than 0.2 mg/dL is considered deficient (Jacob & 
Sotoudeh, 2002). Tissue concentrations of AA and DHA vary greatly depending 
on the tissue type. The highest concentrations of vitamin C are found in the 
adrenal and pituitary glands, and smaller amounts are found in the liver, spleen, 
pancreas, kidney and brain (Hornig, 1975). Because vitamin C is a polar 
compound of relatively large molecular weight, flux in and out of cells is 
controlled by specific mechanisms including active transport and facilitated 
diffusion. Active transport of DHA is facilitated by glucose transporters (GLUT), 
and active transport of AA is facilitated by sodium-dependent cotransporters 
(SVCT) (Wilson, 2005). 
  Vitamin C and its metabolites are filtered by the glomerulous in the 
kidney, and are reabsorbed at the proximal tubule through active transport (Rose, 
1986). Excess AA is excreted as urine. At an intake of 500 mg, approximately 
70% of the dose is absorbed; however, about half of the absorbed dose is excreted 
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unmetabolized in urine (Levin, Conry-Cantilena, Wang, et al, 1996). With a 
higher dose of 1250 mg, only 50% of it is absorbed and >85% of the absorbed 
dose is excreted. These findings suggest that vitamin C is efficiently regulated in 
the body; and thus, vitamin C is relatively nontoxic. However, a Tolerable Uptake 
Level (UL) has been set at 2,000 mg due to adverse effects such as nausea, 
osmotic diarrhea, and gastrointestinal distress (Food and Nutrition Board and 
Institute of Medicine, 2000). High doses of vitamin C have been shown to 
increase urinary oxalate excretion, which may contribute to the development of 
kidney stones (Massey, 2005). Therefore, individuals who are at risk for kidney 
stones should not supplement vitamin C over 500 mg per day. 
 Sources & Recommended Intake. The best dietary sources of vitamin C 
include a variety of vegetables, fruits and juices, some of which are listed in 
Table 1. The vitamin C content of the fruits and vegetables depends on the 
stability of the molecule, which can readily be influenced by oxygen, pH, heat, 
and metallic ions; consequently, AA can become oxidized and cannot function at 
its optimal level (Lopez, Krehl & Good, 1967). This means that the essential 
functions of AA, such as antioxidant protection, are lost. Some cooking practices 
and prolonged storage can cause the degradation of vitamin C. For example, 50 to 
80% of vitamin C is lost from boiling vegetables (Vanderslice & Higgons, 1991). 
However, steaming vegetables in minimal amounts of water can substantially 
decrease the loss of vitamin C from cooking (Rumm-Kreuter & Demmel, 1990). 
Vitamin C is also well preserved in frozen foods suggesting the importance of 
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purchasing frozen vegetables and frozen concentrate orange juice (Johnston & 
Bowling, 2002).  
Table 1. Examples of vitamin C-rich foods. 
Food, Standard Amount Vitamin C Content (mg) 
Red pepper, raw, ½ cup 
Orange juice, ¾ cup 
Kiwifruit, 1 medium 
Grapefruit juice, ¾ cup  
Broccoli, cooked, ½ cup 
Strawberries, fresh, ½ cup 
95 
93 
71 
70 
51 
49 
National Institutes of Health 
 
 In general, most people would assume that fresh orange juice bought at the 
local supermarket is packed with vitamin C; however, due to the environment, 
much of the molecule can be destroyed by the time it gets to the consumer. One 
study compared the vitamin C content of commercial orange juice brands over an 
eight-day period (Johnston & Hale, 2005). At day 8, the orange juice that was 
refrigerated after reconstitution from frozen concentrate had significantly less 
bioavailable vitamin C compared to its baseline amount. Furthermore, vitamin C’s 
protective property as a plasma antioxidant was diminished compared to its 
baseline value. This is a very influential factor in the vitamin C status of 
individuals worldwide since the majority of food items are transported, stored, 
and processed before purchased.  
 The resulting AA concentration in serum after absorption is not 
proportional to the amount ingested, which strongly affects the dietary 
recommendations for vitamin C (Rumsey & Levine, 1998). To prevent scurvy, 
adults must consume ~10 mg/d of vitamin C (Levine, Rumsey, Daruwala, et al; 
1999); however, the Recommended Dietary Allowance (RDA) has been set at 90 
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mg/d for men and 75 mg/d for women (Levine, Wang, Padayatty et al., 2001). 
These RDAs, established a decade ago, should maintain near-maximum 
neutrophil AA concentrations with minimal urinary excretion (Jacob & Sotoudeh, 
2002).  
 The RDA is based primarily on the prevention of deficiency rather than 
the prevention of chronic disease and promotion of optimal health (National 
Research Council, 1989). The optimal intake of vitamin C is likely to be higher 
than the RDA and vary depending on the individual. Remarkably, an NHANES 
study conducted from 1976-1980 found that nearly 20% of Americans consume 
less than 60 mg of vitamin C daily and about 10% consume less than 30 mg 
(Koplan, Annest, Layde & Rubin, 1986). A more recent NHANES study 
conducted between 2003 and 2004 concluded that vitamin C status in the US 
population has substantially improved although deficiency in various subgroups, 
such as smokers and low-income persons, is still of concern (Schleicher, Carroll, 
Ford & Lacher, 2009). Pharmacokinetic trials in young healthy men and women 
have identified that leukocytes became saturated between intakes of 100 and 200 
mg of vitamin C/d (Levine, Conry-Cantilena, Wang, et al., 1996). Furthermore, 
there is evidence that >500 mg/day is necessary to achieve plasma saturation and 
maximize antioxidant protection (Johnston & Cox, 2001). Additional research is 
needed to reexamine the recommended level of vitamin C ingestion to optimize 
its protective functions. 
 The established RDAs are based on healthy adults; however, factors such 
as sex, age, or clinical condition could alter the absorption and transportation of 
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the compound. As indicated above, studies have shown that females need less 
vitamin C per day than males (Biard et al, 1979; Levine Conry-Cantilena, Wang, 
et al., 1996). This is because females on average have smaller lean body masses 
and maintain a higher plasma AA concentration at a given intake (Institute of 
Medicine, 2000). Some epidemiologic studies show that the elderly, especially 
those institutionalized, have a lower vitamin C status than young adults (Institute 
of Medicine, 2000). This is most likely due to low dietary intake, less efficient 
absorption, or clinical conditions such as repeated infections; however no special 
RDA has been established for elderly people. Smokers have an increased 
recommendation (125 mg/d for males and 110 mg/d for females) due to either 
increased AA catabolism or the debilitating oxidative stress of smoking (Higdon 
& Frei, 2002). Finally, those suffering from a clinical condition such as cancer, 
diabetes, or cardiovascular disease, may benefit from increased vitamin C 
consumption (Li & Schellhorn, 2007). The exact mechanisms through which 
vitamin C can relieve the onset and progression of degenerative disease is specific 
to each illness; however, its antioxidant properties are strong contributing factors 
in most cases (Li & Schellhorn, 2007).  
 Functions. Oxygen is essential for aerobic life; however, about 5% of 
inhaled oxygen is converted to reactive oxygen species (ROS) (Bandyopadhyay, 
Das & Banerjee, 1999). ROS, such as superoxide (O2-), hydrogen peroxide (H2O2) 
and hydroxyl radical (.OH), cause oxidative stress and deregulate cell functions 
leading to illnesses such as cardiovascular disease and cancer (Taniyama & 
Griendling, 2003). They are generated through normal physiological processes as 
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well as environmental stressors, and can cause substantial oxidative damage to 
lipids, cell proteins, and nucleic acids.  
 Four enzymes work to defend the body from the damage of ROS: 
superoxide dismutase, glutathione peroxidase, heme peroxidase, and catalase 
(Bandyopadhyay, Das & Banerjee, 1999). A secondary defense against ROS is 
termed  ‘scavengers’. These ‘scavengers,’ also known as antioxidants, react with 
the dangerous radical compounds to produce less harmful molecules (Ogawa, 
Suzuki, Okutsu, Yamazaki & Shinkai, 2008). AA is a powerful antioxidant and, 
thus, is essential to minimize oxidative stress in the body. 
 Recent evidence has shown that AA may also act as a pro-oxidant, 
promoting DNA damage in vitro; however it is uncertain if this occurs in vivo 
(Carr & Frei, 1999). Pro-oxidation happens when free transition metals are 
reduced by AA and then react with hydrogen peroxide. These metals, such as 
copper and iron, lead to the synthesis of highly reactive hydroxyl radicals (Li & 
Schellhorn, 2007).  
 AA also plays a critical role as a co-antioxidant for regenerating α-
tocopherol, a form of vitamin E with saturated side chains. This regeneration is 
very important since in vitro experiments have shown that the oxidized form, α-
tocopheroxyl radical, can act as a prooxidant in the absence of co-antioxidants 
(Chappell et al., 2002). Sustaining α-tocopherol levels limits peroxidation of cells 
and therefore maintains cell integrity (Mandl, Szarka & Banhegyi, 2009). 
 Similar to its antioxidant properties, AA also functions as a cofactor by 
maintaining metal ions in a reduced state, which is necessary for enzyme activity 
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(Padh, 1991). Several hydroxylases and mono-oxygenases depend on AA. One 
major physiological function is that AA serves as a cofactor in collagen synthesis. 
Collagen is the most prevalent protein in mammalian bodies (Spanheimer & 
Peterkofsky, 1984). Of the 8 enzymes that vitamin C acts as a cofactor, 3 
participate in collagen hydroxylation: prolyl-4-hydroxylase, prolyl-3-hyrdoxylase, 
and lysyl-hydroxylase. With the help of AA, hydroxyl groups are added to the 
amino acid lysine or proline in order to make the collagen molecule more stable 
(Padayatty et al, 2003). The symptoms that develop due to a vitamin C deficient 
state are mostly related to defective collagen synthesis—bone and connective 
tissue disorders, tooth loss, and blood vessel fragility.  
 Carnitine plays a critical role in energy metabolism, specifically the 
transport of fatty acids across the mitochondrial membrane (Johnston, Corte, & 
Swan, 2006). This is essential for tissues whose primary source of energy is fatty 
acids such as skeletal and cardiac tissue. Ascorbic acid is a cofactor for two 
enzymes used in the production of carnitine, timethyllysine dioxygenase and 4-
gamma-butyrobetaine dioxygenase (Rebouche, 1991). Specifically, ascorbic acid 
reduces iron to its ferrous (Fe2+) state, which is necessary for this enzymatic 
pathway to function. Fatigue and weakness are early signs of scurvy and can be 
linked directly to defective carnitine production (Hughes, Hurley & Jones, 1980). 
In a study where guinea pigs were fed high fat diets, those that were also given 
high doses of AA maintained 50% more heart and skeletal muscle carnitine 
compared to the AA deficient group (Rebouche, 1991). Another study found that 
free-living participants with marginal vitamin C status oxidized 25% less fat per 
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kg body weight during an hour long treadmill test compared to those with 
adequate vitamin C status (Johnston, Corte & Swan, 2006). 
 Synthesis of specific neurotransmitters and hormones require vitamin C to 
reduce copper to its cuprous (Cu1) state in order for enzyme activity to take place. 
Vitamin C acts as a cosubstrate for dopamine-ß-monooxygenase, which converts 
the neurotransmitter dopamine to norepinephrine (Wimalasena, & Wimalasena, 
1995). The results of deficient neurotransmitter conversions can explain some of 
the symptoms of scurvy—depression and mood swings. Vitamin C is also 
involved in the activation of hormones and hormone-releasing factors that involve 
α-amidations in the posttranslational steps (Murth, Keutmann & Eipper, 1987). 
Petidylglycine α-amindating mono-oxygenase catalyzes α-amindations and is AA 
dependent. Without vitamin C, essential hormones such as vasopressin, oxytocin, 
cholecystokinin, and gastrin could not be synthesized (Oldham et al., 1992). The 
important role of vitamin C in steroid hormone synthesis is shown through its 
high concentration in the adrenal glands (Patak, Willenberg & Bornstein, 2004).  
 During times of high stress, the adrenal glands release stress-response 
hormones, most notably being cortisol. These ‘fight or flight’ hormones trigger 
the body to prepare for action, and can affect the body negatively, including 
immune function (Ebrecht, Hextall, Kirtley et al., 2004), when present for 
prolonged periods of time. Vitamin C may act as an antioxidant and work to 
reduce the release of stress hormones from the adrenal gland (Peters, 1997). 
Studies have shown that supplementation with antioxidant mixtures for up to two 
months can significantly reduce cortisol responses to prolonged exercise (Fischer 
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et al, 2004; Vassilakopoulos et al, 2003). More research is warranted on vitamin 
C’s ability to decrease cortisol release during times of stress.  
 Role in Disease States. Supplementation of vitamin C provides a 
protective influence on many disease states including vascular disease, cancer, 
and the main purpose of this review, the common cold (Li & Schellhorn, 2007; 
Jacob &Sotoudeh, 2002). Much research has investigated the therapeutic effects 
of vitamin C and the mechanisms by which the nutrient provides beneficial effects 
for chronic disease states.  
 Many epidemiological studies have found an inverse relationship between 
vitamin C intake and incidence of cardiovascular disease. Data from the National 
Health and Nutrition Examination Survey (NHANES) conducted from 1976-1980 
revealed an 11% decrease in cardiovascular disease and stroke incidence for every 
0.5 mg/dL rise in serum vitamin C (Jacob & Sotoudeh, 2002). One critical 
molecule of the cardiovascular system is nitric oxide (NO), which is necessary for 
healthy endothelial function (Carr & Frei, 1998). NO induces vasodilatation and 
inhibits potentially dangerous processes such as smooth muscle proliferation and 
platelet aggregation from occurring (Frei, 1997). AA, especially with tocopherol, 
may function to scavenge superoxide radicals which can readily inactivate NO 
(Carr & Frei, 1998). One study concluded that treatment with vitamin C (500 
mg/d for 4 weeks) can improve endothelium-dependent vasodilatation in patients 
with coronary artery disease, angina pectoris, hypercholesterolemia, hypertension, 
or diabetes (Gokce, Keaney, Frei, et al., 1999). In another study, researchers 
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found that vasodilatation was increased in participants by supplementing 1,000-
2,000 mg/d of oral AA (Duffy, Gokce & Holbrook et al, 1999) 
 Additionally, vitamin C can decrease the prevalence of cardiovascular 
disease by decreasing hypertension (Duffy, Gokce & Holbrook et al, 1999; Hajjar, 
George & Sasse et al, 2002). In a cross-sectional study conducted in the UK with 
more than 500 men and women, plasma AA levels were inversely related to 
diastolic and systolic blood pressure (Skyrme-Jones et al., 2000). In another study 
where healthy people were fed a vitamin C deficient diet for 30 days followed by 
a vitamin C adequate diet for another 30 days, plasma ascorbate levels were 
inversely related to diastolic blood pressure (Block, 2002). Other clinical trials 
have conflicting results indicating that more research is needed in regards to the 
role of supplemental vitamin C in reducing cardiovascular disease risk. 
 Numerous epidemiological studies provide evidence that diets high in 
fruits and vegetables are related to decreased risk of some cancers (Carr & Frei, 
1999). Many studies suggest that the link between high fruit and vegetable diets 
and decreased cancer risk is due to high vitamin C content of these food items 
(Szeto, Tomlinson & Benzie, 2002; Rossing, Vaughan, McKnight, 1989). 
Vitamin C’s protective influence is stronger with cancers of the oral cavity, 
pharynx, esophagus, and stomach. Additionally, meta-analyses have shown an 
inverse relationship between high vitamin C intakes and decreased risk (20%) for 
breast cancer (Gandini, Merzenich, Robertson et al, 2000). A longitudinal study 
observed 870 men for 25 years and found that those who consumed >83 mg/d of 
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vitamin C had a marked 64% decrease in lung cancer incidence compared to those 
that consumed <63 mg/d (Sandras et al., 2001).  
 Observational studies have linked increased dietary vitamin C to 
decreased risk of stomach cancer (Mirvish, 1994). Theoretically, vitamin C 
present in gastric juice inhibits the formation of N-nitroso carcinogens in the 
stomach. Helicobacter pylori is a bacterial infection that has been linked to an 
increased risk for stomach cancer and also lowers the vitamin C content in gastric 
secretions (Jarosz, Dzieniszewski, Dabrowska-Ufniarz et al, 1998). Vitamin C 
supplementation in addition to other therapies has been a suggested treatment 
option for patients suffering with this condition.  
 The possible mechanisms for a decreased risk of cancer with vitamin C is 
thought to involve its role as an antioxidant and its ability to detoxify carcinogens 
or block carcinogenic processes (Block, 1992; Block, Patterson, Subar, 1992; 
Carpenter, 1991). Although there is evidence supporting vitamin C’s ability to 
reduce the risk for esophageal cancer, lung cancer, and breast cancer, the trials 
have not been able to distinguish between the influence of vitamin C and other 
components of vitamin C-rich fruits and vegetables. Furthermore, some studies 
suggest that vitamin C may hinder anticancer therapies via its antioxidant 
properties, which may promote tumor cell integrity (Perrone et al., 2009). 
Because results for studies regarding cancer risk and vitamin C supplementation 
are so conflicting, more research is needed in order to offer safe, effective advice 
to cancer patients.  
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 The publication of Vitamin C and the Common Cold by Linus Pauling in 
1970 stirred up public debate about vitamin C’s role in immune function. His 
hypothesis rested on the discovery that leukocytes had high concentrations of 
vitamin C, which rapidly declined during times of stress and infection (Higdon & 
Frei, 2002). Pauling advocated that the optimal daily intake of vitamin C for an 
adult consuming 2500 kcal/d should be 2300 mg/d. Numerous epidemiologic, 
clinical, and biochemical studies conducted since Pauling’s published work have 
deciphered a much more moderate vitamin C level between 100 and 200 mg/d to 
be associated with tissue saturation and reduced risk for chronic diseases in 
healthy adults (Carr & Frei, 1999; Levine, Rumsey, Daruwala et al, 1999). Even 
though Pauling’s views on vitamin C supplementation have been criticized, he is 
still seen as a pioneer in the health field that stimulated interest in the role of 
micronutrients to promote optimal health and prevent chronic diseases.  
 The interest in vitamin C’s role with the immune function and its ability to 
treat the symptoms of the common cold has stirred continued research in order to 
determine the mechanisms behind the proposed immunocompetence and the 
specific populations that would benefit. Current research provides evidence that 
Vitamin C aids the immune system through its antioxidant properties, direct 
antimicrobial function, and/or effect on immune system modulators such as 
histamine (Jacob & Sotoudeh, 2002). Several trials have been conducted, 
however, there is still one question that cannot be fully answered: Is 
supplementations of vitamin C an effective measure in treating the common cold?  
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Upper Respiratory Tract Infections 
 Physiology. The respiratory system includes the nose and nasal cavity, 
mouth, pharynx (throat), larynx (voice box), trachea, bronchi, and lungs (Marieb, 
2004). Its main function is to supply the body with oxygen and excrete carbon 
dioxide. This process, called respiration, consists of four processes. The first is 
pulmonary ventilation, which is the movement of air in and out of the lungs. This 
process ensures that gases are continually circulated and refreshed. The second 
step of respiration is external respiration. This is the incorporation of oxygen into 
the blood and the removal of carbon dioxide from the blood. Transport of 
respiratory gases, the third step of respiration, is the transfer of oxygen from the 
blood to the tissue cells of the lungs. The final step, internal or cellular 
respiration, involves the exchange of oxygen in the blood to tissue cells 
throughout the body (Marieb, 2004).  
 In addition to supplying oxygen to the body, the respiratory system also 
works to protect the body from harmful toxins that can be inhaled. The respiratory 
tract is lined with a mucus membrane and hair-like structures called cilia, which 
trap and remove particles such as pollution, smoke, or pathogens (Dugdale, 2008).  
 Prevalence and Transmission of URIs. Upper respiratory tract infections 
(URI) are the most common acute illness in the US with Americans suffering 1 
billion colds per year (NIAID, 2001). On average, children endure 6 to 10 colds 
per year, and adults get 2 to 4 colds per year (NIAID, 2001). Consequently, adults 
on average lose 8.7 work hours per cold incidence, and students lose a total of 189 
million school days each year due to the common cold (Bramley, 2002). This 
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tremendous heath-related loss in productivity contributes to the significant 
economic burden caused by the common cold. Colds cost Americans and their 
healthcare providers approximately $40 billion each year—$17 billion from direct 
medical costs and $22.5 billion from indirect costs (Fenrick et al, 2003). The 
economic burden of the common cold is greater than conditions such as 
congestive heart failure, high blood pressure, asthma, and migraines (Fenrick et 
al, 2003). 
 The rhinovirus is highly contagious. It can be transmitted through various 
mechanisms including aerosol, droplet, or direct hand-to-hand contact with 
infected secretions followed by contact with the nasal mucosa or conjunctivae 
(Musher, 2003). A quantitative study that examined the transfer of respiratory 
viruses to and from fingers of adult subjects found that 37.8% of rhinovirus could 
still be detected 1 hour after contamination and nearly 16% after 3 hours (Ansari, 
Springthorpe & Sattar et al, 1991). Furthermore, a systemic review conducted on 
the persistence of pathogens found that rhinovirus could be detected on dry 
inanimate surfaces up to 7 days after contamination (Kramer, Schwebke & 
Kampf, 2006). Thus, transmission occurs more commonly in crowded areas, one 
great example being a college dorm.  
 Infection & Treatment. The “common cold” refers to acute rhinosinusitis, 
which is caused by viral infection of the upper respiratory tract mucosa (Rabkin). 
Symptoms include nasal congestion and/or discharge, sneezing, sore or dry throat, 
and headache. The onset of symptoms occurs 1 to 3 days after exposure to a 
pathogen, and symptoms of the cold generally last from 1 to 2 weeks (Piccirillo, 
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2004; Sande & Gwaltney, 2004). Most colds are caused by four different families 
of viruses: rhinovirus, coronavirus, adenovirus, and respiratory syncytial virus 
(Cooper, Hoffman, Bartlett et al, 2001). The infection rates of the particular virus 
vary by season; however, the symptoms of the four viruses are almost 
indistinguishable (Rabkin). Seeking treatment for colds is a major reason for 
doctor visits; however, doctors can do little to treat the illness since antibiotics are 
not effective against viruses (Anon, 2010). 
 Although there is substantial evidence that antibiotics do not cure the 
common cold (Gonzales, Steiner & Maselli, 2001), almost 75% of adults with 
URIs are prescribed antibiotics by their doctors (Hirschman, 2002). 
Astonishingly, unnecessary prescriptions for URIs and bronchitis represent 31% 
of total antibiotic prescriptions in the US (Rabkin) and account for $700 million 
in medical costs per year (Gonzales, Steiner & Maselli, 2001). So why are doctors 
still prescribing antibiotics for cold symptoms?  
 The answer in the literature is two-fold: a) the patient may benefit from 
the antibiotic or b) the patient expects antibiotics. Although it is possible for a 
bacterial infection to coincide with a viral infection, the chances are small. 
Furthermore, prescribing antibiotics without evidence of a bacterial infection can 
cause harm to the patient. In a cross-sectional survey, researchers found that 82% 
of subjects with common cold symptoms such as runny or obstructed nose, cough 
or sore throat were prescribed antibiotics to treat the symptoms (Kumar, Indira & 
Rizvi, 2008). Antibiotics were more likely to be prescribed in private than 
government settings, and in rural than urban settings. Additionally, it is possible 
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that a patient expects their physician to give them a medication to treat their 
symptoms, which can sway a doctor’s judgment.   
 In contrast with the notion that all patients expect antibiotics when visiting 
a doctor, studies have shown that a patients’ satisfaction is independent of 
whether or not antibiotics are prescribed. Instead, the satisfaction is related more 
closely to if the physician addressed the patients’ concerns by providing 
information and giving verbal advice, even if that means explaining why 
antibiotics will not benefit the patient (Arrol, Kenealy & Kerse, 2002).  
 The use of antibiotics not only fails to cure the common cold but can 
contribute to the rise of drug-resistant bacterial infections and the risk for allergic 
reactions (Anon, 2010). Antibiotics can also destroy the healthy gut bacteria 
leading to gastrointestinal discomfort (Lode, 2010). Although antibiotics cannot 
cure the common cold, the body is not completely defenseless. The extraordinary 
mechanisms of the immune system can detect and eliminate pathogenic agents 
including viruses that cause the common cold.  
 The Immune System & URIs. The immune system is composed of a 
network for cells, tissues, proteins and organs that protect the body from invading 
pathogens such as viruses, bacteria, and parasites. It can detect toxic agents and 
distinguish them from healthy cells and tissues. When activated, lymphocytes 
proliferate and release inflammatory mediators such as proinflammatory 
cytokines (IL-1; IL-6) (Wintergerst, Maggini, & Hornig, 2006). When produced 
by lymphocytes, interleukin-1 (IL-1) has a paracrine effect by signaling the 
surrounding cells to trigger a blood clot cascade, stimulate the synthesis of other 
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interleukins, and activate T cells and thus the adaptive immune response 
(Bendtzen, 1988). IL-6 works to stimulate the immune system by increasing 
energy metabolism. Through this process, the infection is isolated and cells are 
signaled to begin the healing process; however, excessive release of IL-1 can 
result in inflammation, fever, and tissue damage (Dinarello, 2000).   
 Once triggered by antigen, the immune system is primed and can tackle 
specific pathogens more efficiently at future infection. This process is known as 
“acquired immunity” and contributes to immunological memory (NIAID, Immune 
System, 2010). Generation of ROS is a mechanism for host defense used to kill 
viruses or other invading pathogens intracellularly; however, ROS can also 
interfere with immune cell communication and damage other biomolecules such 
as PUFAs.   
 Many factors contribute to the ability of the immune system to do its job, 
one of the most important being diet (Starnbach, 2010). Just as for any system of 
the body, the immune system cannot perform at its optimal level without proper 
nourishment. A community-based longitudinal study in rural Bangladesh 
examined the relationship between nutritional status, cell mediated immune 
response, and incidence of acute upper respiratory tract infections (Zaman, Baqui 
& Yunus et al, 1997). This year-long study included 696 children ages 0-59 
months. Approximately three quarters of whom were below -2 z-score weight for 
age and height for age. The study found that incidence of upper respiratory tract 
infections was 16% greater in the classified malnourished children than in 
adequately nourished children. The study also found that anergic children (e.g., 
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children whose immune system is unresponsive) had a 20% higher risk for URI 
than immunocompetent children. This evidence supports the theory that cell 
immunity is directly related to nutritional status. 
 Because diseases commonly coexist with micronutrient deficiencies, 
underprivileged populations in developing countries are common victims of 
infections such as HIV/AIDS, tuberculosis, malaria, and measles (Bhaskaram, 
2002). In a randomized controlled trial of 200 Zambian children suffering from 
severe malnutrition and diarrhea, researchers found that children given either a 
routine nutritional rehabilitation diet or elemental diet were free of diarrhea after 
one month (Amadi, Mwiya, Chomba et al, 2005). Additionally, fecal samples 
were taken at the beginning and end of the study to measure pathogenic protozoa. 
Results showed that host defense improved with the nutrition intervention 
suggesting that virulence is associated with host defenses and thus can be 
modulated by nutritional status (Hughes & Kelly, 2006).  
 The idea of “boosting” immunity through nutritional supplements has 
been a highly debated topic in the health field for years (Goldrosen & Straus, 
2004). The theory suggests that specific nutrients and/or minerals can enhance the 
efficiency and effectiveness of the immune system and thus decrease incidences 
of illnesses caused by pathogens. Nutrient deficiencies may impair the proper 
functioning of various immune processes, which are critical for host defense. 
Antioxidants (Bandyopadhyay, Das & Banerjee, 1999), especially vitamin C 
(Beetens & Herman, 1983), could play a major role in preventing tissue damage 
from immune-system-generated ROS, especially in populations with poor dietary 
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habits. Research investigating the topic of immunity is immense, however there is 
still much that is inconclusive.  
 
Vitamin C and Upper Respiratory Track Infections 
  Vitamin C is a major nutrient that has been linked to immunity, 
specifically decreasing upper respiratory track infections. There are many 
mechanisms by which vitamin C aids the immune system including decreasing 
oxidative stress (Bandyopadhyay, Das, & Banerjee, 1999), enhancing production 
of the defense collagens that populate the pulmonary tissues (Behndig, Blomberg, 
Helleday, Kelly, & Mudway, 2009), promoting leukocyte motility, and reducing 
circulating histamine concentrations (Johnston, Martin, & Cai, 1992). These 
properties are the foundation for the hypothesis that vitamin C supplementation 
can decrease the incidence and severity of the common cold.  
 Decreasing Oxidative Stress. Oxidative stress is the result of reactive 
oxygen species (ROS), which cause damage to cells and tissues in the body. It 
contributes to the process of aging and can lead to the development of disease. 
ROS, such as superoxide (O2-) and the very reactive hydroxyl radical (.OH), are 
byproducts of oxygen reduction in the body (Bandyopadhyay, Das, & Banerjee, 
1999). Because ROS are molecules with unpaired electrons, they can damage 
vital cell components such as proteins, polyunsaturated fatty acids, and nucleic 
acids. These reactions can alter membrane fluidity, protein synthesis, and can 
cause DNA damage. Ultimately, ROS can lead to cell death. AA reduces ROS 
activity by donating electrons to neutralize these molecules (Rose & Bode, 1993). 
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Oxidized AA, DHA, is then readily reduced back to AA through glutathione or 
enzymatic reduction making it an efficient combater of oxidative stress (Rumsey 
& Levine, 1998). 
 Lipid peroxidation, a result of ROS damage, occurs in polyunsaturated 
fatty acids (PUFA) and effects cell membrane fluidity, permeability, and cellular 
metabolic functions (Bandyopadhyay, Das, & Banerjee, 1999). Chemically, the 
methylene C-H bonds of PUFAs are prone to hydrogen abstraction because of the 
adjacent double bond. A randomized controlled trial investigating the ability of 
AA to decrease lipid peroixdation in relation to the pathogenesis of 
atherosclerosis found that supplementation of 500 mg vitamin C/d for 2 months 
resulted in a ~10% reduction in lipid peroxidation (Huang, Appel, Croft et al., 
2002). The antioxidant properties of AA reduce the amount of oxidative stress in 
the body allowing physiological systems, including the immune system, to 
operate more efficiently. 
 Promoting Leukocyte Mobility. Leukocytes are white blood cells that play 
a major role in the immune system by protecting the body from infectious 
pathogens. Vitamin C is highly concentrated in leukocytes, and the recycling 
process of AA is especially efficient in leukocytes suggesting its importance to 
the immune system (Rumsey & Levine, 1998). Exposure of neutrophils to 
microbial pathogens can actually increase AA recycling 30-fold (Jacob & 
Sotoudeh, 2002). Neutrophil chemotaxis is an important part of immune response. 
Through this process, chemotactic agents signal neutrophils and other serum 
factors to the site of infection in order to contain and destroy pathogens. Although 
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more evidence is needed, studies suggest that vitamin C, through its ability to 
suppress histamine, may indirectly promote chemotaxis and therefore promote 
immune function (Johnston, Martin, Cai, 1992; Anderson, 1981).  
 Enhancing Production of Defense Collagens in Pulmonary Tissues. The 
lungs are particularly susceptible to oxidative damage due to exposure to toxins 
present in inhaled air. Many pollutants, including bacteria and viruses, are 
powerful oxidants and could potentially cause significant damage to lung tissue. 
However, the pulmonary epithelium is lined with respiratory tract lining fluid 
(RTLF), which is heavily populated with antioxidants such as AA and glutathione 
(van der Vliet et al., 1999). It has been proposed that these antioxidants in the 
RTLF may help neutralize and eliminate inhaled toxins and decrease tissue 
damage by activating defense collagens on neutrophils in the airways (van der 
Vliet et al., 1999). Neutrophils can then contain and destroy invading pathogens 
that may have been inhaled. In vitro studies have shown that AA is directly 
oxidized by free radical gases, ozone and nitrogen dioxide (Kelly & Tetley, 
1997). In vivo studies have also shown that AA is oxidized in the RTLF when 
exposed to nitrogen dioxide (Kelly et al., 1996). These observations emphasize 
the importance of AA to protect the lung lining and suggest that protection against 
air toxins, including pathoens, may be increased by augmenting RTLF AA 
concentrations.  
  In a randomized controlled trial, researchers set out to see if augmentation 
of RTFL ascorbate concentrations could protect the lung tissue from air toxins 
and airway inflammatory episodes (Behndig, Blomberg, Helleday et al., 2009). 24 
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subjects with low plasma ascorbate concentrations were recruited and the 
experimental group received 60 mg/day of vitamin C for two weeks. Dosage 
increased in increments of 250, 500, and 1000 mg of vitamin C throughout the 
time period of the experiment. The results illustrated that acute vitamin C 
supplementation (1g) has a rapid, but transient, increase in AA concentrations in 
RTLF. Ascorbate in nasal RTLF samples more than doubled after just 2 hours 
after supplementation (1.1 µΜ at baseline to 2.6 µΜ), more than tripled after 4 
hours (3.6 µM), and returned to pre-supplementation levels around 24 hours. This 
instant antioxidant protection may provide protection to lung tissue as well as 
decrease oxidative stress and inflammation in airways.  
 Although the exact mechanism is unknown, it is believed that RTFL 
ascorbate concentrations are a result of passive paricellular transport from the 
plasma to the airway lining; therefore, increasing plasma AA concentrations will 
increase antioxidant protection in the airways (Behndig, Blomberg, Helleday et 
al., 2009). Through redox reactions, AA can neutralize potential free radical 
damage from inhaled toxins (Kelly et al, 1996). The protective influence of 
vitamin C in the respiratory tract may decrease the incidence of the cold by 
eliminating infections caused by inhaled pathogenic toxins. 
 Histamine. Histamine is involved in numerous physiological processes 
including vasoconstriction and vasodilation, allergic reactions, and 
neurotransmission (Falus & meretey, 1992). It is also a critical molecule in the 
initial stages of an immune response by providing a signal of “alertness”. When 
the body identifies a foreign invader, histamine increases capillary permeability 
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and smooth muscle contraction (Plaut & Lichtenstein, 1982). This mechanism of 
immunoresponsiveness triggers the flow of immune factors to the inflammatory 
site. Shortly after, histamine suppresses the immune cells by activating T-
supressor cells and the Histamine Suppressor Factor (HSF). This is possibly to 
contain the inflammatory effect (Busse & Sosman, 1976).  
 Vitamin C acts as an antihistamine and can inhibit the immunosuppressive 
actions of histamine. In vitro studies have illustrated that AA breaks the imizadole 
ring structure of histamine, inhibiting its ability to function (Uchida, Mitsui & 
Kawakishi, 1989). Additionally, vitamin C may compete with histamine for the 
H1 receptor site on cells in the respiratory tract and blood vessels (Woo, 2008). 
Because histamine is a mediator for symptoms of URIs, it is possible that vitamin 
C may function to reduce cold symptom severity by reducing concentrations or 
actions of histamine. Possibly, AA would inhibit the inflammatory process and 
decrease cold symptoms such as congestion.  
 A randomized controlled trial analyzing 437 human blood samples found 
that when plasma AA fell below 1 mg/100 ml, blood histamine levels increased 
exponentially (Clemetson, 1978). However, 1 g of vitamin C per day for 3 days 
resulted in the reduction of histamine in all 11 selected volunteers. Another study 
involving healthy men and women, ages 19-47, found that ingestions of 2 grams 
of vitamin C per day resulted in a 38% decrease in histamine levels in just 2 
weeks (Johnston, Martin & Cai, 1992). In fact, histamine degradation may be able 
to provide a valid measure to detect subnormal, non-scorbutic vitamin C status 
before scurvy develops (Johnston, Solomon  & Corte, 1996).  
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 Current Evidence. When investigating the effect of vitamin C 
supplementation on treating the common cold, it is important to account for is the 
baseline AA status of study participants. Participants with adequate AA tissue 
saturation would be less likely to show a benefit with vitamin C supplementation 
as compared to participants with AA deficiency. Because of this, recruiting 
individuals with low to marginal plasma vitamin C would be most useful. Several 
studies have shown that subjects in the UK have particularly low plasma AA 
levels, most likely due to diet (Hemila, 1997). A randomized controlled trial with 
1524 British men and women sought to see if 10 g of AA taken the first 3 days of 
cold symptom onset would decrease the severity of symptoms reported. 
Researchers concluded that AA supplementation is “of no value in the treatment 
of the common cold” (Tyrrell, Wallace, Meade & White, 1977). 
 Another important aspect of research that must be accounted for to 
strengthen internal validity of a study is dietary intake of vitamin C. Completely 
restricting vitamin C-rich foods from the diet would ensure that the results are do 
to the supplemented vitamin C, however it could cause the development of 
deficiency symptoms in the participants. To avoid harming the subjects, diet can 
instead be accounted for through diet assessment measures. The Rapid Eating and 
Activity Assessment for Patients (REAP) survey has been validated against the 
Healthy Eating Index and includes questions to assess intake of whole grains, 
calcium-rich foods, fruits and vegetables, fat, sugary beverages and foods, sodium 
and alcohol. It is used to evaluate the eating behaviors of subjects and provides 
assessment of the diet related to the US Dietary Guidelines (Gans, Risica, Wylie-
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Rosett, et al., 2005). The shortened version of the survey has been validated and 
scores the eating behavior questions as follows: “usually/often” = 1, “sometimes” 
= 2, and “rarely/often” = 3 (Segal-Isaacson, Wylie-Rosett & gGans, 2004). The 
higher the score out of 39 points, the higher the diet quality based on US Dietary 
Guidelines. Food frequency questionnaires, 24-hour recalls, and diet records are 
other diet assessment tools that can be used to collect information on food intake 
and convert to estimates of nutrient intake.  
 Extensive research has been conducted to investigate the efficacy of 
vitamin C supplementation in preventing and treating the common cold. Pauling 
conducted a meta-analysis of four placebo-controlled studies and concluded that 
vitamin C supplementation of at least 100 mg per day decreased the incidence of 
common cold episodes by 45% (Pauling, 1971). However, since this finding, 
other studies have found no substantial effect between the experimental and 
placebo groups (Hemila, Chalker & Douglas, 2010). In a double blind trial with 
1000 subjects taking 4000 mg/d at the onset of a cold, researchers sought to 
reevaluate Pauling’s findings (Anderson, Reid & Beaton, 1972). They found that 
the average number of colds and days of sickness was less for the vitamin C 
group than the placebo group, but the differences were small and not statistically 
significant. However, they did find a significant difference between groups for the 
number of participants who did not contract any illness during the study: 26% in 
the vitamin C group as compared to 18% of the control group. This could suggest 
that vitamin C may be an effective prevention measure in terms of the common 
cold.  
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 Another randomized, controlled trial found an 18% decrease in ‘chest 
colds’ (cough, difficulty breathing) but no effect in the incidence of ‘simple colds’ 
(runny nose or sneezing) (Elwood, Lee, Leger, Baird, & Howard, 1976). A similar 
study found a 21% decrease in ‘throat colds’ but no effect in ‘nose colds’ 
(Anderson, Reid & Beaton, 1972). These findings suggest that vitamin C 
supplementation may be more effective in treating symptoms of certain types of 
cold infections.   
 A recent meta-analysis of 29 placebo-controlled trial comparisons with 
over 11,000 subjects found that regular supplementation of vitamin C had no 
effect on the incidence of the common cold in the general population (Hemila, 
Chalker, & Douglas, 2007). However, there were modest decreases duration and 
severity of cold symptoms in those people under high physical stress, such as a 
marathon runner or skier. Those who supplemented vitamin C had a 50% less risk 
of contracting the common cold. A recent study that surveyed 37 triathletes found 
that 97% supplemented vitamin C and 48% did so to prevent or reduce common 
cold symptoms (Knez & Peake, 2010). This finding is supported by a randomized 
controlled trial with 92 runners who took 600 mg of vitamin C daily (Peters, 
Goetzsche, Grobbelar & Noakes, 1993). After a competitive ultramaration race 
(>42 km), subjects were monitored for cold symptoms. 68% of runners in the 
placebo group reported symptoms of a URI in comparison to 33% in the vitamin 
C group. It may be that vitamin C supplementation is beneficial for specific 
subpopulations, such as extreme athletes, in fighting the common cold.  
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 Another very interesting study aimed to investigate dietary vitamin C’s 
relationship with self-reported respiratory symptoms in 4300 young smokers in 
Norway (Omenaas, Fluge, Buist, et al., 2003). Researcher’s concluded that dietary 
vitamin C was inversely related to “morning cough,” “chronic cough,” “wheeze,” 
and “wheeze ever.” This finding suggests that high dietary vitamin C intake may 
decrease the prevalence of smoking-related respiratory symptoms by acting as an 
antioxidant and reducing cough and wheeze in smokers with high oxidant stress 
(Block, 1996).  
 One major trial investigating the effect of vitamin C on the common cold 
monitored subjects for 3.5 years (Sasazuki, 2006). The long time span of the trial 
is highly beneficial because it was able to cover multiple seasons, giving the 
results credibility. In the trial, there was a low dose group (50 mg VC/d) and a 
high dose group (500 mg VC/d). Interestingly enough, researchers found that the 
high dose group about 3 times less incidence of the common cold compared to the 
low-dose group; however, there was no observed effect on duration or severity 
which may be due to methodological errors. Because the mixed findings in this 
study and others, much more valid and reliable research is necessary to determine 
if vitamin C supplementation is effective in treating the common cold. 
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Chapter 3 METHODOLOGY 
 Subjects & Study Design. Healthy college men, aged 18-35, were recruited 
through flyer distribution and college department ListServs on the Arizona State 
University campus for this two-treatment parallel-design study. Initial contact by 
phone call (Appendix A) was used to determine if those interested met medical 
history, diet, and physical activity requirements for the study. Eligible individuals 
were scheduled for a screening visit (study visit 1).  
 Exclusion criteria for subjects included regular smoking >10 times a day 
several times a week (Moran, Wechsler, & Rigotti, 2004), BMI >35, daily use of 
dietary supplements containing >60 mg of vitamin C, and/or use of prescription 
medications for chronic conditions. Subjects’ vitamin C plasma concentrations 
from the screening visit had to be below 0.80 mg/dL in order for them to 
participate in the 8-week trial. Training athletes or those who were engaged in 
purposeful, vigorous exercise more than five times a week were also excluded. 
This randomized, double-blind, parallel arm study was approved by the 
Institutional Review Board at Arizona State University.  
 A power analysis was calculated using a probability of 0.05 and a power of 
0.8. Based on previous studies measuring plasma vitamin C concentrations, a 
standard deviation of 0.2 was used to determine sample size. We anticipate a 
change in plasma vitamin C to be 0.2 mg/dL. Using a verified sample size 
calculator, 34 participants were deemed adequate. A total of 43 subjects were 
recruited, with 30 attending the screening and becoming enrolled in the study. 
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This allowed for 15 subjects per group. One subject was withdrawn from the 
study due to issues with compliance. Additionally, one subject was excluded 
because his results from the WURSS-21 survey were greater than 3 standard 
deviations from the mean. In all, 15 subjects were in the VC group and 13 were in 
the placebo group.  
 After providing written consent (Appendix B), BMI, weight/height, 
postprandial blood sample (no food or drink with the exception of water for 5 
hours), Rapid Eating Assessment for Participants Questionnaire (REAPS), 24-
hour food recall, and a Medical History Questionnaire were completed at the first 
study visit (Appendix C). Participants who met the inclusion criteria were 
stratified by age, BMI, and plasma vitamin C concentrations and randomly 
assigned to either the experimental or the control group. The experimental group 
(VTC) was instructed to ingest the capsule (500 mg vitamin C) twice daily, once 
in the morning and once in the evening. The control group (CON) was instructed 
to ingest the capsule (a flour placebo identical in appearance to the vitamin C 
capsule) twice daily, once in the morning and once in the evening. Subjects were 
requested not to drink any fruit drinks or juices during the study. They were told 
to consume the pill with food if there was any sign of gastrointestinal distress.  
 At the study baseline (study visit 2), all subjects were given a booklet, 
which contained copies of the Wisconsin Upper Respiratory Symptom Survey-21 
(Appendix C) to record their daily symptom status and the use of any 
medications, herbal supplements, or lozenges taken to relieve respiratory 
symptoms. The booklet also included a food frequency questionnaire (Appendix 
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C) to be competed weekly to account for dietary vitamin C consumption during 
the course of the study. Survey booklet compliance was checked at week 1 (study 
visit 3) and the booklets were turned in at weeks 4 and 8 (study visits 4 and 5). 
Fasting blood samples (no food or drink with the exception of water for 8 hours) 
for plasma vitamin C were drawn again at weeks 4 and 8. Fasting blood samples 
for histamine analyses were drawn again at week 8. A second REAPS was also 
completed at week 8 (study visit 5). At these visits, subjects also completed 
several measuring tools that were used for a separate study (POMs and Godin-
Leisure Time Exercise Questionnaire).  
 Blood Analyses. Plasma vitamin C was determined using the 2,4-
dinitrophenylhydrazine method of Omaye et al. A 1 ml aliquot of plasma was 
mixed with 1 ml ice-cold 10% trichloroacetic acid. Following centrifugation 
(3500 x g, 0˚C), the supernatant was frozen (-80˚C) and vitamin C analysis was 
performed on the sample in 7 days (Johnston & Martin, 1992). The histamine was 
quantitively acylated and analyzed using an ELISA kit with the microtiter plate 
format. (ALPCO Diagnostics, 2010) (Appendix D). 
 Wisconsin Upper Respiratory Symptom Survey—21. The Wisconsin Upper 
Respiratory Symptom Survey (WURSS-21) is a standardized measure for 
evaluating the signs and symptoms of the common cold (Appendix C). It consists 
of 21 questions: a global severity indicator, 19 symptom-severity items using 7-
point severity scales, and one comparative question referring to symptom severity 
the previous day.  The WURSS-21 has been tested and is a reliable and valid 
method for examining the incidence, severity, and duration of the common cold 
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(Barrett et al, 2009).  
 The survey assessed symptom severity and functional impairment, with a 
score of 1 considered to be very mild; 3, mild; 5, moderate; and 7, severe. In this 
study, summing the scores of the first 10 questions provided a measure of 
symptom severity, summing the scores of the second 9 questions provided a 
measure of functional impairment, and summing all 19 items provided a global 
measure of illness severity. Perception of sickness was indicated by a question 
that asked, “How sick are you today?” Again, results were recorded on a 
magnitude scale with 1 considered to be very mild; 3, mild; 5, moderate; and 7, 
severe. 
 Statistical Analysis. Data were reported as means ± SE. Data were analyzed 
using repeated measures through analysis of variance (ANOVA). Statistical 
analysis was performed using the SPSS Statistical Analysis System 19.0. Data 
were tested for normality and transformed if necessary. Outliers of more than 3 
standard deviations from the mean were excluded from the results. Nonparametric 
measures were used when data were not normally distributed. Within- and 
between-group differences were expressed as mean percent difference (95% Cl). 
Differences were considered significant at p ≤ 0.05.   
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Chapter 4 DATA & RESULTS 
 Recruitment took place from January to February of 2011. Of the 43 
participants screened, 30 were enrolled, stratified by age, BMI, and plasma 
vitamin C concentrations, and randomly assigned to either the control (CON) 
group or the vitamin C group (VTC). This allowed for 15 subjects per group. One 
subject was withdrawn from the study due to issues with compliance. 
Additionally, one subject was excluded because his results from the WURSS-21 
survey were greater than 3 standard deviations from the mean. Hence for data 
analysis, 15 subjects were in the VTC group and 13 were in the CON group. Age 
ranged from 18 to 32 years, though the mean age was similar in both groups 
(23.00±0.79 in VTC and 23.36±1.12 in CON). Baseline height, weight, BMI, 
percent body fat, and REAPS scores were also similar between the VTC and CON 
groups indicating proper stratification for the study (Table 2.). Baseline plasma 
histamine was significantly different between the CON and VTC groups, 
0.356±0.247 and 0.667±0.628 respectively (p=0.043). Baseline plasma vitamin C 
was below US norms for this age group in both groups (0.52±0.03) (Schleicher, 
Carroll, Ford & Lacher, 2009). Additionally, baseline plasma vitamin C status of 
the participants was inversely related to body weight (r=-0.579, p=0.001; Figure 
1.) as well as BMI, and percent body fat.  
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Table 2. Baseline Characteristics of Participants1,2     
  All VTC CON   
  (n=28) (n=15) (n=13) P-value3 
Age (y) 23.0±0.7 23.0±0.8 23.2±1.2 0.913 
Height (in) 71.0±0.4 71.9±0.5 69.0±0.7 0.026 
Weight (lb) 181.1±4.0 182.5±5.2 179.6±6.3 0.720 
BMI (kg/m2) 25.2±0.7 24.6±1.0 26.0±1.1 0.348 
Body fat (%) 19.0±1.2 17.5±1.7 20.7±1.8 0.201 
Plasma VC 
(mg/dL) 0.523±0.029 0.532±0.039 0.513±0.047 0.744 
Plasma histamine 
(ng/mL) 0.522±0.507 0.667±0.628 0.356±0.247 0.043 
REAPS 31±0.6 31±0.8 31±0.9 0.133 
1VTC - vitamin C group; CON - placebo group; REAPS - diet quality analysis 
at weeks 0 & 8; Plasma VC was collected 5-hours post meal 
2Values reported as means ± SE.     
3Analysis by independent t-test    
 
Figure 1. Relationship between baseline body weight and plasma vitamin C status 
 
 
 Plasma vitamin C was significantly higher in the VTC group compared to 
the CON group at week 4 of the study, 0.726±0.049 and 0.541±0.056 respectively 
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(p=0.019) (Table 3.). There was also a significant difference between the groups 
at week 8, (VTC was 0.742±0.47 and CON was 0.597±0.53; p=0.051). Plasma 
histamine fluctuated only slightly over the 8-week trial, -4.2% in the VTC group 
and +17.4% in the CON group (p=0.562) (Figure 2). There was a 94.5% 
compliance rate for subjects taking the pills, which was determined by the number 
of pills returned at weeks 4 and 8. Because the only diet restriction placed on the 
subjects was to avoid fruit juices, a weekly Food Frequency Questionnaire (FFQ) 
was conducted to account for milligrams of vitamin C consumed by the 
participants. Dietary vitamin C intakes (mg/d) determined from weekly FFQ 
analyses averaged over trial weeks 1-4 and trial weeks 5-8 did not differ by group 
(p=0.107 and 0.958 respectively). Additionally, diet quality was assessed using 
the Rapid Eating Assessment for Participants Questionnaire at weeks 0 and 8. 
There was no change in diet quality by group over the study period (p=0.133). 
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Table 3. Plasma Indices & Dietary Data at Study Weeks 4 & 81, 2   
  Week 0 Week 4 Week 8 P-value3 
Plasma histamine 
(ng/mL)       0.562 
VTC  0.667±0.628 ND 0.639±0.277   
CON 0.356±0.247 ND 0.431±0.298   
REAPS    0.133 
VTC 31±0.8 ND 32±0.9   
CON 31±0.9 ND 30±1.3   
Fasting Plasma  
VC (mg/dL)      
VTC  ND 0.726±0.049 0.742±0.047 0.019 (wk4) 
CON  ND 0.542±0.056 0.597±0.053 0.051 (wk8) 
FFQ (mg VC)      
VTC ND 85±10 101±11 0.107 (wk4) 
CON ND 113±14 102±19 0.958 (wk8) 
1VTC - vitamin C group (n=15); CON - placebo group (n=13); REAPS - diet 
quality analysis at weeks 0 & 8; ND- No data 
2Values reported as means ± SE.     
3Between group comparisons: repeated measures ANOVA for Plasma Histamine 
& REAPS; Independent t-test for Plasma VC & FFQ 
4FFQ recorded as average of weeks 1-4 and average of weeks 5-8. 
 
 
Figure 2. Plasma histamine group comparison over 8-weeks 
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 The Wisconsin Upper Respiratory Symptom Survey-21 was used to track 
common cold symptoms during the 8-week study (Table 4.). Scores are arbitrary 
units that represent the magnitude of symptoms. The average total symptoms 
reported for the entire 8 weeks for the VTC group was 43±15 compared to 
148±36 in the CON group—a 244% difference in symptoms (p=0.014) (Figure 
3). Looking at only the first 10 questions of the survey gives insight into symptom 
severity reported. Symptoms assessed included “runny nose”, “plugged nose”, 
“sore throat”, “cough”, and “chest congestion.” The VTC group reported 
significantly less severity of symptoms compared to the CON group, 31±10 and 
101±25 respectively (p=0.031). The second 9 questions of the survey focuses on 
functional impairment such as decreased ability to sleep well, work outside the 
home, and interact with others. There was a greater amount of functional 
impairment related to cold symptoms reported by the CON group (46±15) 
compared to the VTC group (18±10); however, the results did not attain statistical 
significance (p=0.058). Overall, there was a 65% lower reported perception of 
sickness in the VTC group than the CON group (p=0.022) (Figure 4).  
Table 4. Cold Symptom Analysis of WURSS-21 Survey over 8-
Weeks1,2   
  All VTC CON   
  (n=28) (n=15) (n=13) P-value3 
Average Total Symptoms 92±109 43±15 148±36 0.014 
    Symptom Severity 63±76 31±10 101±25 0.031 
    Functional Impairment 31±48 18±10 46±15 0.058 
Perception of Sickness 11±2 6±2 17±4 0.022 
1VTC - vitamin C group; CON - placebo group; WURSS-21 - Cold Symptom 
Survey 
2Values reported as means ± SE; Units are an arbitrary measure of magnitude 
3Analysis by nonparametric independent samples test (Mann-Whitney U) 
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 1Units are an arbitrary measure of magnitude. Symptoms are reported over 
 56 days, in 4-day increments. (1=very mild; 3=mild; 5=moderate, 
 7=severe) 
 2One subject was excluded because initial day was an extreme outlier 
 value (n=27). 
Figure 3. Comparison of cold symptoms reported by the VTC and CON groups 
over the course of the study 
 
 
 
 1Units are an arbitrary measure of magnitude. Symptoms are reported over 
 56 days, in 4- day increments. (1=very mild; 3=mild; 5=moderate, 
 7=severe) 
Figure 4. Comparison of perception of sickness reported by the VTC and CON 
groups over the course of the study 
 
 To control for the possibility that allergy symptoms may have had some 
influence on the results, any report of allergies or use of allergy medications on 
the medical history questionnaire as well as the WURSS-21 survey was taken into 
account. Only one participant reported using an allergy medication daily. 
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Significance of the results were maintained when controlling for this subject 
(p<0.05).  
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Chapter 5 DISCUSSION 
 In this double-blind, randomized controlled trial, vitamin C 
supplementation reduced the perception of sickness and reported cold symptom 
severity compared to placebo. These results support the daily supplementation of 
1000 mg vitamin C by college men to reduce cold symptoms such as cough, 
congestion, and sore throat. These findings are consistent with other studies that 
reported decreased severity of specific cold symptoms with vitamin C 
supplementation (Elwood, Lee, Leger, et al., 1976; Anderson, Reid & Beaton, 
1972). Anderson et al. conducted a randomized controlled trial with 818 subjects 
and found that those taking 4000 mg of vitamin C per day had a 21% decrease in 
‘throat colds’ but no effect in ‘nose colds’ compared to the placebo group. A 
similar study conducted by Elwood et al. observed 688 women for 100 days. They 
found that those supplementing 1000 mg of vitamin C per day had an 18% 
decrease in ‘chest colds’ (cough, difficulty breathing) but no effect in ‘simple 
colds’ (runny nose or sneezing) compared to the placebo group. 
 It is important to note that the participants began this study with low-
adequate vitamin C status and that these results are likely limited to this 
population. Baird et al. concluded that males benefited more so from vitamin C 
supplementation than females in terms of total number of symptoms reported and 
especially in duration of cold symptoms (1979). Another double-blind survey also 
found that males had less reported colds than females when taking AA 
supplements for 15 weeks (Clegg, 1974). This is most likely due to the fact that 
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young males generally have lower plasma AA than females (Schleicher, Carroll, 
Ford & Lacher, 2009) because females on average have smaller lean body masses 
and maintain higher AA concentrations at a given intake (Institute of Medicine, 
2000). Therefore, compared to females, males are more likely to have low-
adequate AA status and benefit from the vitamin C supplementation. 
 There are multiple functions of vitamin C that can account for its ability to 
decrease common cold symptom severity. Through vitamin C’s function as an 
antioxidant, it is able to react with dangerous radical compounds known as 
reactive oxygen species (ROS) and produce less harmful molecules (Ogawa, 
Suzuki, Okutsu, Yamazaki & Shinkai, 2008). ROS have unpaired electrons and 
can cause substantial damage to vital cell components such as proteins, 
polyunsaturated fatty acids, and nucleic acids effecting membrane fluidity, protein 
synthesis and DNA synthesis (Rose & Bode, 1993). This function of vitamin C 
reduces the amount of oxidative stress in the body and therefore allows 
physiological systems, including the immune system, to operate more efficiently. 
Of particular interest is the ability of AA to reduce harmful pathogens inhaled 
through the lungs (Behndig, Blomberg, Helleday et al., 2009) since inhalation is a 
mode of virus transmission (Musher, 2003). With a strong immune system, the 
body can be more effective at fighting off the virus that causes the common cold.  
 Vitamin C has also been linked to promoting leukocyte mobility, an 
essential aspect of the immune system to protect the body from invading 
pathogens (Rumsey & Levine, 1998). Although more evidence is needed, some 
studies suggest that vitamin C may indirectly promote leukocyte mobility through 
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its ability to suppress histamine (Johnston, Martin & Cai, 1992; Anderson, 1981). 
By promoting quick action when there is an invading pathogen, cold symptom 
severity may be decreased by vitamin C.    
 Because of its role in the immune system, histamine is a mediator of cold 
symptoms (teary eyes, stuff nose, sneezing, etc.) (Busse & Sosman, 1976). It is 
possible that the benefit of vitamin C supplementation for cold symptom relief is 
related to its antihistamine function. However, in our study, plasma vitamin C 
concentrations did not reach levels necessary to observe an anti-histamine effect. 
Previous research shows that the antihistamine effect of vitamin C is not observed 
until plasma vitamin C levels are above 1.0mg/100ml (Johnston, Retrum & 
Srilakshmi, 1992). Because the subjects in this study had plasma vitamin C levels 
below 1.0mg/100ml, the reduction in cold symptoms noted herein cannot be 
explained by the antihistamine role of vitamin C. Rather, it is likely related to the 
protective effects that vitamin C has in lung tissues and/or promotive effects 
vitamin C has on the immune system or antioxidant properties than may lessen 
damage and inflammation.   
 It is especially interesting to see that the rise and fall of recorded cold 
symptoms (Figure 5.) over the 8-week period is similar between the VTC and the 
CON group; however, the VTC group had significantly lower cold symptoms 
even at peaks of apparent illness. This relationship was emulated in a similar 
study. A double-blind, randomized controlled trial conducted over 3 years with 
244 subjects also found nearly identical peaks of cold incidence for the ‘high-
dose’ group (500 mg vitamin C/day) and the ‘low-dose’ group (50 mg vitamin 
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C/day), however the peaks were consistently lower for the ‘high-dose’ group 
(Sasazuki et al., 2006). These results, however, conflict with previous research 
that has concluded vitamin C supplementation has no effect on the incidence of 
the common cold (Hemila, Chalker, & Douglas, 2010).  
 The WURSS-21 is a valid measurement for assessing magnitude of cold 
symptoms and performs as an “illness-specific quality-of-life evaluate outcome 
instrument” (Barrett et al, 2009). To the author’s knowledge, there is only one 
other study that has used the WURSS-21 survey for research purposes (Barrett, 
Brown, Rakel, et al., 2010). Because there is no gold standard for identifying, 
classifying, or assessing colds, it can be difficult to compare results of similarly 
structured studies. It is important to note that this study analyzed ‘perception of 
sickness’ which could include other ailments other than common cold symptoms. 
For more comparable results, future studies using the WURSS-21 survey should 
explain that questions about ‘sickness’ pertain to cold symptoms only. 
 To maintain internal validity of the study, dietary assessment measures 
were included in the methodology. The shortened REAPS survey was used at 
weeks 0 & 8 to investigate dietary behaviors of subjects and determine diet 
quality scores in terms of US Dietary Guidelines. Through this validated survey 
(Segal-Isaacson, Wylie-Rosett & Gans, 2004), diet quality scores are calculated 
out of a total of 39 possible points where “usually often” = 1, “sometimes” =2, 
and “rarely/often” = 3. The higher the score, the higher the diet quality. The VTC 
group had average scores of 31±08 at week 0 and 32±0.9; CON had 31±0.9 at 
week 0 and 30±1.3 at week 8. In this study, REAPS scores in both the VTC and 
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CON groups did not significantly change over time (p=0.133). Supported by 
insignificant calculations of milligrams of vitamin C consumed by the VTC group 
compared to the CON group (p=0.107 at week 4 and p=0.958 at week 8) 
throughout the course of the study, we can conclude that changes in dietary 
vitamin C did not confound these results.  
 An interesting observation showed that baseline vitamin C status was 
inversely related to body weight. This finding is consistent with other literature 
(Johnston, Beezhold, Mostow & Swan, 2007; Canoy, Wareham, Welch et al, 
2005) although the exact mechanism is unknown. More research is necessary to 
determine if vitamin C supplementation plays a part in weight management.  
 Limitations. This study has limitations. First of all, the 8-week duration is 
fairly short compared to other studies, especially since having a cold was not a 
specified inclusion criteria. Thus, a participant could have complied with 
instructions but simply was not exposed to a cold virus during the short time 
period of observation. A longer period of observation over various seasons would 
provide a more complete assessment. Also, although the power analysis suggested 
34 participants, there were only 28 subjects in this study due to recruitment 
restrictions and compliance issues. Another factor to consider is that sickness and 
severity of symptoms is a subjective measure. What one person considers a 
‘severe cough’ may not agree with another person’s perception. Also, compliance 
was not strictly recorded but was assessed by pill return counts. Even though pill 
counts indicated a 96% compliance, it may be that compliance for capsule 
consumption twice daily as a divided dose was not high.  
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 Strengths. One study strength is that all participants were young males, the 
US sample most likely to have the lowest vitamin C status compared to the 
population at large (Schleicher, Carrol, Ford & Lacher, 2009). Hence, on average, 
participants began the study with low-adequate vitamin C status and tissues were 
not vitamin C saturated. Results showed significance in fasting plasma vitamin C 
between the VTC and CON groups at weeks 1-4 (p=0.019) and at weeks 5-8 
(p=0.051). Also, subjects were not regular smokers or training athletes, both of 
which call for an increase in vitamin C intake due to the physiological stress 
placed on the body (Jacob & Sotoudeh, 2002; Schleicher, Carrol, Ford & Lacher, 
2009). Since diet quality and weekly ingestion of vitamin C rich foods was 
monitored through the REAPS survey and weekly FFQs we were able to 
eliminate diet as a confounding factor in the results. Restriction of fruit juices 
contributed to minimizing the impact of vitamin C consumption through the diet. 
Additionally, medical history surveys and reported medications taken during the 
study were examined in order to prevent confusion between allergy symptoms 
and cold symptoms.  
 Conclusion. In summary, this randomized controlled trial suggests that 
perception of sickness and reported symptom severity were reduced with vitamin 
C supplementation (1000 mg/d) compared to placebo. These results support the 
ability of vitamin C to decrease the physiological burden of the common cold. 
Future research should investigate vitamin C’s effect on the duration of the 
common cold and plasma histamine levels over a longer period of time.  
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Nutrient Supplementation and Health Parameters 
Phone Script Name:                                                 1st Contact (Date, Time):                                 2nd Contact (Date, Time):                                 3rd Contact (Date, Time):       Hello       , Thank you for your interest in the Nutrient Supplementation and Health Parameters research study. Do you have time to answer 6 short questions to see if you qualify for the trial? 
If no: When would be a better time? 
If yes: 1. First of all, how old are you?     years  2. Do you currently smoke cigarettes? Yes or No   a. If yes: How often?    b. If “a” answered, ask: Approximately how many cigarettes do you smoke [refer to 
period of time that “a” was answered in]?   c. If “a” and/or “b” answered, ask: Do you usually smoke with others in a social scene or alone?  3. Do you currently take vitamin and mineral supplements?   a. If yes: Which supplements do you take?  4. Do you currently take any prescriptions?   a. If yes: Which prescriptions do you take?  5. Are you currently seeing a doctor for a health condition?   a. If yes: What condition are you being seen for?  6. Do you have any limitations regarding physical activity and exercise? 
→If any of the answers do not meet the requirements for the study, the individual will be 
excluded.  
If meets requirements:  Based on this information, I would like to invite you to be a participant in the Nutrient Supplementation and Health Parameters study. We will be contacting you shortly about the first study visit. Thank you for your time. Have a great day! 
If does not meet requirements:  Unfortunately, we will not be able to accept you into the study. We appreciate your interest and time. Have a great day! Thank you,         . 
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CONSENT FORM 
Nutrient Supplementation and Health Parameters  
INTRODUCTION 
The purposes of this form are to provide you (as a prospective research study participant) 
information that may affect your decision as to whether or not to participate in this research and 
to record the consent of those who agree to be involved in the study. 
 
RESEARCHERS 
Dr. Carol Johnston, director of the Nutrition program at Arizona State University, as well as 
graduate students, Gillean Osterday and Sara Schumacher, have invited your participation in a 
research study. 
 
STUDY PURPOSE 
The purpose of the research is to examine the effect of nutrient supplementation in young 
college males, aged 18‐40, on immune function and psychological status.  
 
DESCRIPTION OF RESEARCH STUDY 
If you decide to participate, then as a study participant you will join a study to evaluate the effect 
of ingestion of a nutrient supplement twice daily for 8 weeks on health markers. You will be 
instructed to complete a one‐page questionnaire daily regarding illness and three one‐page 
questionnaires each week regarding physical activity and diet. If you are interested in joining the 
study, you will be asked to come to an initial screening where a fasting blood sample (no food or 
drink for 5 hours with the exception of water) will be drawn, your body weight and height will be 
measured, and you will complete health history, diet, and mood questionnaires. If you are 
eligible for the study, you and the other participants will be randomly placed in either the control 
(placebo) or experimental (nutrient supplement) group. Subjects will be asked to visit the 
research site on 7 occasions at 0, 1, 2, 4, 7 and 8 weeks. At weeks 0, 4, and 8, a blood sample 
(requiring overnight fasting for 8 hours) will be drawn, you will be weighed, and you will 
complete mood and physical activity questionnaires.  At each blood sampling approximately 4 
tablespoons of blood will be collected.  At the study visits, you will need to bring in the 
questionnaire booklet on diet, illness, and physical activity. We will also ask you to wear a 
pedometer at your waist for 2 three‐day periods at the start and end of the study. 
 
If you say YES, then your participation will last for 8 weeks at the Polytechnic campus of Arizona 
State University. Approximately 40 of subjects will be participating in this study locally. 
 
RISKS 
There may be a slight chance of gastrointestinal distress when the supplement is taken on an 
empty stomach.  This risk is reduced if you ingest the nutrient supplement with a meal.  Blood 
draws may cause light‐headedness or temporary bruising.  A nurse or trained phlebotomist will 
be performing the blood draws.     
 
BENEFITS   
Although there may be no direct benefits to you, the possible benefits of your participation in the 
research is that you will be able to experience what it is like to be a part of a research study that 
may provide new evidence for health promotion for many college students.  
 
NEW INFORMATION 
If the researchers find new information during the study that would reasonably change your 
decision about participating, then they will provide this information to you. 
 
CONFIDENTIALITY 
All information obtained in this study is strictly confidential unless disclosure is required by law. 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The results of this research study may be used in reports, presentations, and publications, but 
the researchers will not identify you. Your name will not be associated with any data pertaining 
to the study. In order to maintain confidentiality of your records, Dr. Carol Johnston will assign 
you a subject number which will be used to identify you throughout the entire course of the 
study. 
 
WITHDRAWAL PRIVILEGE 
It is ok for you to say no. Even if you say yes now, you are free to say no later, and withdraw from 
the study at any time. Your decision will not affect your grades or any relationship with Arizona 
State University or otherwise cause a loss of benefits to which you might otherwise be entitled. 
 
COSTS AND PAYMENTS 
The researchers want your decision about participating in the study to be absolutely voluntary. 
Yet they recognize that your participation may pose some costs. In order to help defray your 
costs you will receive two $10 gift card incentives at the 0 and 4‐week visits and a $15 gift card at 
week 8 for a total of $35.  
 
COMPENSATION FOR ILLNESS AND INJURY 
If you agree to participate in the study, then your consent does not waive any of your legal rights. 
However, no funds have been set aside to compensate you in the event of injury.  
 
VOLUNTARY CONSENT 
Any questions you have concerning the research study or your participation in the study, before 
or after your consent, will be answered by Dr. Carol Johnston, Principal Investigator and 
Professor of Nutrition at ASU (480‐ 727‐1713), Gillean Osterday, Graduate Student (480‐225‐
4262), or Sara Schumacher, Graduate Student (480‐694‐5159). 
 
If you have questions about your rights as a subject/participant in this research, or if you feel you 
have been placed at risk; you can contact the Chair of the Human Subjects Institutional Review 
Board, through the ASU Office of Research Integrity and Assurance, at 480‐965 6788.   
 
This form explains the nature, demands, benefits and any risk of the project.  By signing this form 
you agree knowingly to assume any risks involved.  Remember, your participation is voluntary.  
You may choose not to participate or to withdraw your consent and discontinue participation at 
any time without penalty or loss of benefit.  In signing this consent form, you are not waiving any 
legal claims, rights, or remedies.  A copy of this consent form will be given (offered) to you.   
 
Your signature below indicates that you consent to participate in the above study.   
 
___________________________  _________________________  ____________ 
Subject's Signature      Printed Name        Date 
 
Preferred contact:  phone or email:  __________________________________________ 
 
INVESTIGATOR’S STATEMENT 
"I certify that I have explained to the above individual the nature and purpose, the potential 
benefits and possible risks associated with participation in this research study, have answered 
any questions that have been raised, and have witnessed the above signature. These elements of 
Informed Consent conform to the Assurance given by Arizona State University to the Office for 
Human Research Protections to protect the rights of human subjects. I have provided (offered) 
the subject/participant a copy of this signed consent document." 
 
Signature of Investigator______________________________________     Date_____________
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APPENDIX C SUBJECT QUESTIONNAIRES  
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HEALTH /HISTORY QUESTIONNAIRE                                ID#___________________ 
1. Gender:  M    F 
 
2. Age:  __________  
3. Have you lost or gained more than 5 lbs in the last 12 months?         Yes         No      If yes, how much lost or gained? _________     How long ago? ___________  
4. College Status (please circle)    Fresh.      Soph.     Jr.     Sr.     Grad. 
 
5. Ethnicity: (please circle)  Native American     African-American     Caucasian     
Hispanic     Asian     Other  6. Do you smoke?  No, never ________                      Yes _______     # Cigarettes per day = ________                                                              I used to, but I quit _______ months/years (circle) ago 
 
7.  Do you take any medications regularly?     Yes No           If yes, list type and 
frequency:      Medication        Dosage        Frequency ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________  8. Do you currently take supplements (vitamins, minerals, herbs, etc.) ?    Yes    No         
If yes, list type and frequency:                                    Supplement        Dosage        Frequency ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________  9.  Have you ever been hospitalized? ______   If yes, for what? _______________________________________           
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10.   Please ANSWER (YES/NO) if you currently have or if you have ever been diagnosed with any of the following diseases or symptoms:     YES  NO    YES  NO Coronary Heart Disease      Chest Pain     High Blood Pressure      Shortness of Breath     Heart Murmur      Heart Palpitations     Rheumatic Fever      Any Heart Problems     Irregular Heart Beat      Coughing of Blood     Varicose Veins      Feeling Faint or Dizzy     Stroke      Lung Disease     Diabetes      Liver Disease     Low Blood Sugar      Kidney Disease     Bronchial Asthma      Thyroid Disease     Hay Fever      Anemia     Leg or Ankle Swelling      Hormone Imbalances     Eating Disorders      Emotional Problems      Please elaborate on any condition listed above.___________________________________________________  11.  How would you rate your lifestyle? Not active ___________         Active ___________ Somewhat active __________       Very Active ___________  12. Please circle the total time you spend in each category for an average 
week.    Light activities such as:   Slow walking, golf, slow cycling, doubles tennis, easy   swimming, gardening   Hours per week:     0  1  2  3  4  5  6  7  8  9  10+    
Moderate activities such as:   Mod. Walking, mod. cycling, singles tennis, mod. swimming,   mod. weight lifting   Hours per week:     0  1  2  3  4  5  6  7  8  9  10+    Vigorous activities such as:   Fast walking/jogging, fast cycling, court sports, fast swimming,   heavy/intense   weight lifting                       Hours per week:     0  1  2  3  4  5  6  7  8  9  10+  13.  How much alcohol do you drink? (average drinks per day)  ___________  
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14.  Do you have any food allergies?          Yes    No       If yes, explain:________________________________________  15. Do you follow a special diet? (weight gain/loss, vegetarian, low‐fat, etc.)   Yes    No                           If yes, explain:  __________________________________________________________________________________ 
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APPENDIX D ELISA PROCEDURE  
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Histamine ELISA Test Procedure 
Allow all reagents and samples to reach room temperature prior to use. 
Measurement in duplicates is recommended.  
 
1. Preparation of reagents 
 
Wash Buffer: Dilute the 20 mL Wash Buffer Concentrate with distilled water to a 
final volume of 1,000 mL. Store the diluted Wash Buffer Concentrate (Wash 
Buffer) at 2 – 8°C. Shelf life: please refer to expiry date indicated on the kit. 
  
Acylation Diluent: The Acylation Diluent has a freezing point of 18.5°C. To 
ensure that the Acylation Diluent is liquid when being used, it must be ensured 
that the Acylation Diluent has reached room temperature and forms a 
homogenous, crystal-free solution before being used. Alternative the Acylation 
Diluent can be stored at room temperature (20 - 25°C) separate from the other kit 
components.  
 
Acylation Reagent: Reconstitute each vial with 1.25 mL Acylation Diluent. The 
Acylation Reagent has to be newly prepared prior to the assay (not longer than 1 
hour in advance). If more than 1.25 mL is needed, pool the contents of 2 or 3 vials 
and mix thoroughly.  
 
2. Sample preparation and acylation 
 
- Pipette 25 µL of standards, 25 µL of controls, 25 µL of plasma samples 
or 50 µL of supernanant from the release test* into the respective 
wells of the Reaction Plate. 
- Add 25 µL of Acylation Buffer to all wells. 
- Add 25 µL of Acylation Reagent to all wells 
- Incubate for 45 min at RT (20 -25°C) on a shaker (approx. 600 rpm) 
- Add 200 µL of distilled water to all wells. 
- Incubate for 15 min at RT (20 -25°C) on a shaker (approx. 600 rpm). 
* For the release test the Histamine Release supplementary kit (available for 
purchase separately. Cat. No. BA E-1100) has to be used. 
 
3. Histamine ELISA 
- Pipette 25 µL of the acylated standards, controls, and the samples into 
the appropriate wells of the Histamine Microtiter Strips. 
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- Pipette 100 µL of the Histamine Antiserum into all wells and cover the 
plate with Adhesive Foil. 
- Incubate for 3 hours at RT (20 -25°C) on a shaker (approx. 600 rpm). 
Alternatively: shake the Histamine Microtiter Strips briefly by 
hand and incubate for 15-20 hours at 2-8°C. 
- Remove the foil. Discard or aspirate the contents of the wells and wash 
each well 4 times thoroughly with 300 µL Wash Buffer. Blot dry 
by tapping the inverted plate on absorbent material.  
- Pipette 100 µL of the Enzyme Conjugate into all wells.  
- Cover plate with Adhesive Foil and incubate for 30 min at RT (20 -
25°C) on a shaker (approx. 600 rpm). 
- Remove the foil. Discard or aspirate the contents of the wells and wash 
each well 4 times thoroughly with 300 µL Wash Buffer. Blot dry 
by tapping the inverted plate on absorbent material.  
- Pipette 100 µL of the Substrate into all wells and incubate for 20-30 min 
at RT (20 -25°C) on a shaker (approx. 600 rpm). Avoid exposure to 
direct sunlight! 
- Add 100 µL of the Stop Solution to each well and shake the microtiter 
plate to ensure a homogenous distribution of the solution. 
- Read the absorbance of the solution in the wells within 10 minutes, using 
a microplate reader set to 450 nm with a reference wavelength 
between 620 nm and 650 nm.  
 
4. Calculation of results 
 
The calibration curve is obtained by plotting the absorbance readings (calculate 
the mean absorbance) of the standards (linear, y-axis) against the corresponding 
standard concentrations (logarithmic, x-axis). Use a non-linear regression for 
curve fitting (e.g., spline, 4-parameter, akima). 
 
Plasma samples and controls: The concentrations of the plasma samples and the 
controls can be read directly from the standard curve.
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